Paper8096416
Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma.
Smyth ET and 5 others. BMJ, 1993. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. Papers, record 8096416. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8096416
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic beta-Agonists | Major topic |
| Albuterol | Major topic |
| Asthma | Major topic |
| Adolescent | |
| Adult | |
| Double-Blind Method | |
| Drug Administration Schedule | |
| Drug Interactions | |
| Female | |
| Forced Expiratory Volume | |
| Heart Rate | |
| Humans | |
| Male | |
| Middle Aged | |
| Potassium | |
| Salmeterol Xinafoate | |
| Stimulation, Chemical | |
| Therapeutic Equivalency |
Source PubMed
Comments and corrections4
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 8098239 | Dose equivalence of drugs for asthma. | https://conductscience.org/library/papers/8098239 | PubMed |
| Comment in | 8490514 | Dose equivalence of drugs for asthma. | https://conductscience.org/library/papers/8490514 | PubMed |
| Comment in | 8490515 | Dose equivalence of drugs for asthma. | https://conductscience.org/library/papers/8490515 | PubMed |
| Comment in | 9240063 | Several studies have shown salmeterol to be more potent than salbutamol for systemic effects. | https://conductscience.org/library/papers/9240063 | PubMed |
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6474387 | Comparison of cumulative and non-cumulative techniques to measure dose-response curves for beta agonists in patients with asthma. | Thorax | 1984 | https://conductscience.org/library/papers/6474387 | PubMed |
| 2 | 7362736 | Salbutamol aerosol causes a tachycardia due to the inhaled rather than the swallowed fraction. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7362736 | PubMed |
| 3 | 2565417 | Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. | Lancet | 1989 | https://conductscience.org/library/papers/2565417 | PubMed |
| 4 | 2330548 | Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. | Thorax | 1990 | https://conductscience.org/library/papers/2330548 | PubMed |
| 5 | 2349198 | The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation. | Postgrad Med J | 1990 | https://conductscience.org/library/papers/2349198 | PubMed |
| 6 | 1975162 | Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis. | Am Rev Respir Dis | 1990 | https://conductscience.org/library/papers/1975162 | PubMed |
| 7 | 1978872 | Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. | Lancet | 1990 | https://conductscience.org/library/papers/1978872 | PubMed |
| 8 | 2014490 | Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. | Thorax | 1991 | https://conductscience.org/library/papers/2014490 | PubMed |
| 9 | 1679981 | A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects. | Am Rev Respir Dis | 1991 | https://conductscience.org/library/papers/1679981 | PubMed |
| 10 | 1346340 | The use of beta-agonists and the risk of death and near death from asthma. | N Engl J Med | 1992 | https://conductscience.org/library/papers/1346340 | PubMed |
| 11 | 1686740 | Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. | Br J Pharmacol | 1991 | https://conductscience.org/library/papers/1686740 | PubMed |
| 12 | 1560164 | The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours. | J Allergy Clin Immunol | 1992 | https://conductscience.org/library/papers/1560164 | PubMed |
| 13 | 1357554 | A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. | N Engl J Med | 1992 | https://conductscience.org/library/papers/1357554 | PubMed |
| 14 | 2904183 | Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. | Thorax | 1988 | https://conductscience.org/library/papers/2904183 | PubMed |
| 15 | 5032708 | Asthma mortality. Why the United States was spared an epidemic of deaths due to asthma. | Am Rev Respir Dis | 1972 | https://conductscience.org/library/papers/5032708 | PubMed |
| 16 | 4901454 | Salbutamol and isoproterenol. A double-blind trial to compare bronchodilator and cardiovascular activity. | N Engl J Med | 1969 | https://conductscience.org/library/papers/4901454 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37709918 | Asthma and COPD: A Focus on β-Agonists - Past, Present and Future. | Handb Exp Pharmacol | 2024 | https://conductscience.org/library/papers/37709918 | PubMed |
| 36430683 | Salbutamol in the Management of Asthma: A Review. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36430683 | PubMed |
| 27713285 | Beta-Adrenergic Agonists. | Pharmaceuticals (Basel) | 2010 | https://conductscience.org/library/papers/27713285 | PubMed |
| 17253458 | Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid. | Cochrane Database Syst Rev | 2007 | https://conductscience.org/library/papers/17253458 | PubMed |
| 15350154 | A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease. | Drug Saf | 2004 | https://conductscience.org/library/papers/15350154 | PubMed |
| 12519616 | Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma. | Cochrane Database Syst Rev | 2002 | https://conductscience.org/library/papers/12519616 | PubMed |
| 10899240 | Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects. | Thorax | 2000 | https://conductscience.org/library/papers/10899240 | PubMed |
| 9487346 | Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma. | Thorax | 1997 | https://conductscience.org/library/papers/9487346 | PubMed |
| 9176539 | Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects. | Thorax | 1997 | https://conductscience.org/library/papers/9176539 | PubMed |
| 9012556 | Dose-response of inhaled drugs in asthma. An update. | Clin Pharmacokinet | 1997 | https://conductscience.org/library/papers/9012556 | PubMed |
| 8693438 | Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol. | Thorax | 1996 | https://conductscience.org/library/papers/8693438 | PubMed |
| 8611886 | Grand Rounds--City Hospital, Nottingham. A complicated case of community acquired pneumonia. | BMJ | 1996 | https://conductscience.org/library/papers/8611886 | PubMed |
| 8490515 | Dose equivalence of drugs for asthma. | BMJ | 1993 | https://conductscience.org/library/papers/8490515 | PubMed |
| 8490514 | Dose equivalence of drugs for asthma. | BMJ | 1993 | https://conductscience.org/library/papers/8490514 | PubMed |
| 8101117 | Bronchodilator treatment in asthma. Regular treatment with beta agonists remains unevaluated. | BMJ | 1993 | https://conductscience.org/library/papers/8101117 | PubMed |
| 8098239 | Dose equivalence of drugs for asthma. | BMJ | 1993 | https://conductscience.org/library/papers/8098239 | PubMed |
| 8091321 | Systemic effects of salbutamol and salmeterol in patients with asthma. | Thorax | 1994 | https://conductscience.org/library/papers/8091321 | PubMed |
| 7858856 | The interaction between salmeterol and beta 2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro. | Br J Pharmacol | 1994 | https://conductscience.org/library/papers/7858856 | PubMed |
| 7848546 | The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology. | Drug Saf | 1994 | https://conductscience.org/library/papers/7848546 | PubMed |
| 7512898 | Long- versus short-acting beta 2-agonists. Implications for drug therapy. | Drugs | 1994 | https://conductscience.org/library/papers/7512898 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8096416
GET https://conductscience.org/api/papers/v1/8096416/authors